1672
C. Bournaud et al. / Tetrahedron: Asymmetry 21 (2010) 1666–1673
6.7 Hz, 1H), 6.42 (dt, J = 15.2 and 1.5 Hz, 1H), 2.66–2.70 (m, 2H),
2.55–2.59 (m, 2H). 13C NMR (100 MHz, CDCl3): d = 199.6, 144.5,
140.4, 133.6, 131.7, 129.4, 127.7, 41.5, 23.8. HRMS (ESI): calcd
d = 9.65 (s, 1H), 8.75 (d, J = 4.1 Hz, 1H), 8.09 (d, J = 7.8 Hz, 1H),
7.98 (d, J = 7.8 Hz, 1H), 7.56 (m, 1H), 3.51 (m, 2H), 2.73 (m, 2H),
2.09 (m, 1H), 1.88 (m, 2H), 1.72 (m, 1H), 1.42–1.61 (m, 2H) ppm.
13C NMR (75 MHz, CDCl3): d = 202.1, 157.4, 150.3, 138.3, 127.5,
122.2, 56.8, 56.0, 34.0, 33.1, 26.4, 24.7 ppm. MS (ESI): 254
[M+H]+. HRMS (ESI): calcd C12H16O3NS [M+H]+254.085, found
254.0839.
C
11H13O3S [M+H]+ 225.0579, found 225.0570.
4.4.9. (E)-5-(Phenylsulfonyl)pent-4-enal 5g
The oxidation reaction was performed according to the general
procedure with alcohol 7 (0.9 mmol.) to afford aldehyde 5g
(340 mg, 46%) as a colourless oil. 1H NMR (400 MHz, CDCl3):
d = 9.75 (s, 1H), 7.92–7.95 (m, 2H), 7.66–7.71 (m, 1H), 7.58–7.63
(m, 2H), 7.00 (dt, J = 6.7and 15.0 Hz, 1H), 6.40 (dt, J = 1.5 and
15.0 Hz, 1H), 2.54 (dt, J = 1.1 and 7.3 Hz, 2H), 2.31–2.37 (m, 2H),
1.85 (q, J = 7.3 Hz, 2H). 13C NMR (100 MHz, CDCl3): d = 201.2,
145.6, 140.5, 133.5, 131.4, 129.4, 127.7, 42.9, 30.6, 20.0. HRMS
(ESI): calcd C12H15O3S [M+H]+ 239.0736, found 239.0739.
4.5.4. 2-(4-Nitro-phenylsulfonylmethyl)-cyclopentane
carbaldehyde 12e
Intramolecular conjugate addition was performed according to
the general procedure with sulfone 5e (26.2 mg, 0.088 mmol) in
dichloromethane with catalyst 21(5.2 mg, 0.03 mmol) at room
temperature during 2.5 h to afford compound 12e (20 mg, 76%).
The enantiomeric excess was determined by SFC (chiralcel OB col-
umn, 2 mL/min, 200 bar, MeOH 10%-2-1-25%, 30 °C), RT: 9.41,
4.5. General procedure for the intramolecular conjugate
addition
12.41. ½a 2D5
ꢃ
¼ ꢀ0:7 (c 0.74, 72% ee, CHCl3). 1H NMR (300 MHz,
CDCl3): d = 9.68 (s, 1H), 8.44 (d, J = 8.6 Hz, 2H), 8.13 (d, J = 8.6 Hz,
2H), 3.14–3.33 (m, 2H), 2.63–2.76 (m, 2H), 2.14 (m, 1H), 1.61–
1.93 (m, 3H), 1.40–1.61 (m, 2H). 13C NMR (75 MHz, CDCl3):
d = 201.8, 151.0, 144.9, 129.7, 124.6, 60.4, 56.8, 33.7, 33.1, 26.6,
24.6. HRMS (ESI): calcd C13H15O5NSNa [M+Na]+ 320.0568, found
320.0577.
To a solution of vinyl sulfone 5 (0.1 mmol) in solvent (2.5 mL)
was added a catalyst (20 mol %) at rt. The evolution of the reaction
was controlled by TLC until completion of the reaction. The organic
solvent was removed under reduced pressure and the crude mix-
ture was purified by flash column chromatography on silica gel
(c-Hex/EtOAc, 8:2) to give cyclopentane 12.
References
4.5.1. 2-Phenylsulfonylmethyl-cyclopentane carbaldehyde 12c
Intramolecular conjugate addition was performed according to
the general procedure with sulfone 5c (25 mg, 0.1 mmol) in dichlo-
romethane with catalyst 20 (6.8 mg, 0.02 mmol) at room tempera-
ture for four days to afford compound 12c (13 mg, 52%). The
enantiomeric excess was determined by SFC (chiralcel OB column,
2 mL/min, 200 bar, MeOH 10%-2-1-25%, 30 °C), RT: 4.26, 7.56.
1. For recent reviews on organocatalysis see: (a) Jarvo, E. R.; Miller, S. J.
Tetrahedron 2002, 58, 2481; (b) Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed.
2004, 43, 5138; (c) List, B.; Seayad, J. Org. Biomol. Chem. 2005, 3, 719; (d) Gaunt,
M. J.; Johson, C. C. C.; McNally, A.; Vo, N. T. Drug Discovery Today 2007, 12, 8; (e)
Dondoni, A.; Massi, A. Angew. Chem., Int. Ed. 2008, 47, 4638; See also special
issues on asymmetric organocatalysis: (f) Acc. Chem. Res. 2004, 37, issue 8; (g)
Adv. Synth. Catal. 2004, 346, issue 9–10; (h) Chimia 2007, issue 5; (i) Chem. Rev.
2007, issue 12; (j) Bertelsen, S.; Jørgensen, K. A. Chem. Soc. Rev. 2009, 38, 2178.
2. List, B.; Lerner, R. A.; Barbas, C. F., III J. Am. Chem. Soc. 2000, 122, 2395.
3. Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122,
4243.
4. For selected reviews on organocatalytic Michael addition see: (a) Tsogoeva, S.
B. Eur. J. Org. Chem. 2007, 1701; (b) Almasi, D.; Alonso, D. A.; Nájera, C.
Tetrahedron: Asymmetry 2007, 18, 299; (c) Sulzer-Mossé, S.; Alexakis, A. Chem.
Commun. 2007, 3123.
5. (a) Mase, N.; Watanabe, K.; Yoda, H.; Takabe, K.; Tanaka, F.; Barbas, C. F., III J.
Am. Chem. Soc. 2006, 128, 4966; (b) Betancort, J. M.; Sakthivel, K.;
Thayumanavan, R.; Barbas, C. F., III Tetrahedron Lett. 2001, 42, 4441; (c)
Betancort, J. M.; Sakthivel, K.; Thayumanavan, R.; Tanaka, F.; Barbas, C. F., III
Synthesis 2004, 1509; (d) Cao, C.-L.; Sun, X.-L.; Zhou, J.-L.; Tang, Y. J. Org. Chem.
2007, 72, 4073; (e) Wang, J.; Yu, F.; Zhang, X.; Ma, D. Org. Lett. 2008, 10,
2561.
½
a 2D0
ꢃ
¼ ꢀ5:5 (c 0.3, 65% ee, CHCl3). 1H NMR (400 MHz, CDCl3):
d = 9.65 (d, 1H, J = 1.7 Hz), 7.92–7.90 (m, 2H), 7.66–7.51 (m, 3H),
3.25–3.10 (m, 2H), 2.74–2.63 (m, 2H), 2.12–2.05 (m, 1H), 1.92–
1.86 (m, 2H), 1.78–1.70 (m, 1H), 1.69–1.52 (m, 1H), 1.48–1.38
(m, 1H). 13C NMR (100 MHz, CDCl3): d = 202.3, 139.6, 134.1,
129.6, 128.2, 60.7, 57.1, 34.4, 33.2, 26.6, 24.9. HRMS (ESI): calcd
C
13H16O3S [M+H]+ 253.0892, found 253.0883.
4.5.2. 2-(3,5-Bis-Trifluoromethyl-phenylsulfonylmethyl)-
cyclopentane carbaldehyde 12b
Intramolecular conjugate addition was performed according to
the general procedure with sulfone 5b (39 mg, 0.1 mmol) in dichlo-
romethane with catalyst 21 (4 mg, 0.02 mmol) at ꢀ15 °C for four
days to afford compound 12b (30 mg, 75%). The enantiomeric ex-
cess was determined by SFC (chiralcel OD column, 2 mL/min,
6. (a) Hayashi, Y.; Gotoh, H.; Hayashi, T.; Shoji, M. Angew. Chem., Int. Ed. 2005, 44,
4212; (b) Wang, J.; Li, H.; Zhu, L.; Wang, W. Adv. Synth. Catal. 2006, 348, 425; (c)
Melchiorre, P.; Jørgensen, K. A. J. Org. Chem. 2003, 68, 4151; (d) Chi, Y.; Gellman,
S. H. Org. Lett. 2005, 7, 4253; (e) Peelen, T. J.; Chi, Y.; Gellman, S. H. J. Am. Chem.
Soc. 2005, 127, 11598; (f) Alonso, D. A.; Kitagaki, S.; Utsumi, N.; Barbas, C. F., III
Angew. Chem., Int. Ed. 2008, 120, 4588.
200 bar, MeOH 1%-10-1-15%, 30 °C), RT: 2.75, 3.08. ½a D20
¼ þ0:5 (c
ꢃ
7. (a) List, B.; Pojarliev, P.; Martina, H. J. Org. Lett. 2001, 16, 2423; (b) Mukherjee,
S.; Yang, J. W.; Hoffmann, S.; List, B. Chem. Rev. 2007, 107, 5471.
1.54, 82% ee, CHCl3). 1H NMR (300 MHz, CDCl3): d = 9.70 (s, 1H),
8.39 (s, 2H), 8.18 (s, 1H), 3.22 (m, 2H), 2.75 (m, 2H), 2.13 (m,
1H), 1.98 (m, 1H), 1.91 (m, 1H), 1.76 (m, 1H), 1.43–1.66 (m, 2H)
ppm. 13C NMR (75 MHz, CDCl3): d = 201.6, 142.2, 133.0 (q,
J = 35 Hz), 128.7, 127.5, 122.0 (q, J = 274 Hz), 60.5, 56.7, 33.5,
33.1, 26.6, 24.6 ppm. MS (ESI): 389 [M+H]+. HRMS (ESI): calcd
8. (a) Enders, D.; Wahl, H.; Papadopoulos, K. Tetrahedron 1997, 53, 1291; (b) Ruiz,
M.; Vicente, O.; Shapiro, G.; Shapiro, G.; Weber, H.-P. Tetrahedron Lett. 1994, 35,
4551; (c) Schick, A.; Kolter, T.; Giannis, A.; Sandhoff, K. Tetrahedron 1995, 51,
11207; (d) Fernandez, M. C.; Quintela, J. M.; Ruiz, M.; Vicente, O. Tetrahedron:
Asymmetry 2002, 13, 233; (e) Fernandez, M. C.; Diaz, A.; Guillin, J. J.; Blanco, O.;
Vicente, M. J. Org. Chem. 2006, 71, 6958; (f) Sulzer-Mossé, S.; Tissot, M.;
Alexakis, A. Org. Lett. 2007, 9, 3749; (g) Capuzzi, M.; Perdicchia, D.; Jørgensen, K.
A. Chem. Eur. J. 2008, 14, 128.
C
15H15O3F6S2 [M+H]+ 389.0646, found 389.0657.
9. (a) Mossé, S.; Alexakis, A. Org. Lett. 2005, 7, 4361; (b) Sulzer-Mossé, S.; Alexakis,
A.; Mareda, J.; Bollot, G.; Bernardinelli, G.; Filinchuk, Y. Chem. Eur. J. 2009, 15,
3204; (c) Quintard, A.; Bournaud, C.; Alexakis, A. Chem. Eur. J. 2008, 14, 7504;
(d) Li, H.; Song, S.; Liu, X.; Deng, L. J. Am. Chem. Soc. 2005, 127, 8948; (e) Liu, T.-
Y.; Long, J.; Li, B.-J.; Jiang, L.; Li, R.; Wu, Y.; Ding, L.-S.; Chen, Y.-C. Org. Biomol.
Chem. 2006, 4, 2097; (f) Zhu, Q.; Lu, Y. Org. Lett. 2009, 11, 1721; (g) Zhang, S.;
Zhang, Y.; Ji, Y.; Wang, W. Chem. Commun. 2009, 4886; (h) Quintard, A.;
Alexakis, A. Chem. Eur. J. 2009, 15, 11109–11113; (i) Quintard, A.; Belot, S.;
Marchal, E.; Alexakis, A. Eur. J. Org. Chem. 2010, 927.
10. (a) Hayashi, Y.; Gotoh, H.; Tamura, T.; Yamaguchi, H.; Masui, R.; Shoji, M. J. Am.
Chem. Soc. 2005, 127, 1608; (b) Fonseca, M. T. H.; List, B. Angew. Chem., Int. Ed.
2004, 43, 3958; (c) Kikuchi, M.; Inagaki, T.; Nishiyame, H. Synlett 2007, 1075;
(d) Nodes, W. J.; Nutt, D. R.; Chippindale, A. M.; Cobb, A. J. A. J. Am. Chem. Soc.
4.5.3. 2-(Pyridine-2-sulfonylmethyl)cyclopentane carbaldehyde
12d
Intramolecular conjugate addition was performed according to
the general procedure with sulfone 5d (25 mg, 0.1 mmol) in dichlo-
romethane with catalyst 21 (4 mg, 0.02 mmol) at room tempera-
ture for 2 days to afford compound 12d (12 mg, 50%). The
enantiomeric excess was determined by SFC (chiralcel OB column,
2 mL/min, 200 bar, MeOH 2%-10-1-15%, 30 °C), RT: 10.01, 10.57.
½
a 2D5
ꢃ
¼ ꢀ10:3 (c 0.57, 67% ee, CHCl3). 1H NMR (300 MHz, CDCl3):